Park Pyeongtak
Reporter
Biowatch Team With a background in Business Administration (MBA), I focus on the pharmaceutical and biotech industries. My goal is to select key information and present it in an easily understandable manner.
Latest Articles
SK Biopharm Receives FDA Approval for Clinical Trial Plan of Alpha-emitting Radiopharmaceuticals
Ligakem Bio Receives ADC Platform Technology Fees from Ono Pharmaceutical
Abl Bio Confirms Positive Effects of Cancer Drug 'ABL111' in Phase 1b Clinical Trial
Bluebird, Phoenix, and... Who Will Be ABL Bio's Next Technology Export Partner?
Celltrion Opens Production Facility in New Jersey Acquired from Eli Lilly
Bukwang Pharmaceutical Selected as Final Acquirer of Korea Union Pharmaceutical... Production Capacity Increased by 30%
Dr. Han Jin-hwan, Formerly of Merck (MSD), Appointed Head of New Drug Research Institute at Ligand Pharmaceuticals
Samsung Bioepis to Directly Sell Ophthalmic Drug Baivubiz in Europe
Powered by 